JOEL JAMES: Open Payments
NPI 1497954937 · KEIZER, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,828 in 103 payments from 17 companies in 2025. Trend: 2023 $2,317 · 2024 $2,356 · 2025 $1,828
Food & beverage: $1,728Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $479 |
| Janssen Biotech, Inc. | 24 | $305 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $149 |
| Novartis Pharmaceuticals Corporation | 6 | $137 |
| Lilly USA, LLC | 7 | $107 |
| UCB, Inc. | 3 | $105 |
| Organon LLC | 3 | $86 |
| GENZYME CORPORATION | 4 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| Galderma Laboratories, L.P. | 3 | $59 |
Products named: SKYRIZI, TREMFYA, RINVOQ, DUPIXENT, COSENTYX, TALTZ, Bimzelx, NEMLUVIO.
Industry payments across OR — which companies pay providers there.
